Skip to main content

Table 4 Hematological value of male rats treated with GlucoMedix® at 28 days

From: GlucoMedix®, an extract of Stevia rebaudiana and Uncaria tomentosa, reduces hyperglycemia, hyperlipidemia, and hypertension in rat models without toxicity: a treatment for metabolic syndrome

Group/dose (mg/kg)

HCT (%)

HGB (g/dl)

WBC Differential Counting

RBC x106cell/uL

WBC x103cell/uL

NEU

MON

EOS

LYM

(%)

(%)

(%)

(%)

250

41.46 ± 0.80

13.90 ± 0.32

59.00 ± 2.92

4.00 ± 1.00

2.40 ± 0.55

32.80 ± 3.11

4.64 ± 0.38

7.16 ± 0.34

1000

43.44 ± 0.88 *

14.76 ± 0.52

59.60 ± 3.21

3.80 ± 0.84

1.60 ± 0.55

35.20 ± 2.86

4.96 ± 0.18*

6.98 ± 0.16

2000

44.54 ± 0.75 *

15.82 ± 0.61*

59.40 ± 2.88

4.20 ± 0.84

1.60 ± 0.89

35.00 ± 3.32

5.04 ± 0.21*

7.36 ± 0.29

Control

40.94 ± 0.60

13.84 ± 0.50

59.20 ± 2.77

3.40 ± 0.55

1.80 ± 0.45

35.60 ± 2.07

4.06 ± 0.26

6.94 ± 0.21

  1. Values are expressed as mean ± SD. n = 5. Parameters include HCT Hematocrit, HGB Hemoglobin, NEU Neutrophils, MON Monocytes, EOS Eosinophils, LYM Lymphocytes, RBC Red blood cells, and WBC White blood cells. * p < 0.05 compared to control group